Next Article in Journal
The Economic Impact of the Transition from Branded to Generic Oncology Drugs
Previous Article in Journal
Special Supplement on Canadian Cancer Costing Research
 
 
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Editorial

Why Are We Organizing Another Costing Supplement in Current Oncology?

Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, ON, Canada
Curr. Oncol. 2019, 26(2), 87-88; https://doi.org/10.3747/co.26.4975
Submission received: 9 January 2019 / Revised: 9 February 2019 / Accepted: 9 March 2019 / Published: 1 April 2019

Abstract

Why are we publishing another costing supplement in Current Oncology? [...]

Share and Cite

MDPI and ACS Style

Mittmann, N. Why Are We Organizing Another Costing Supplement in Current Oncology? Curr. Oncol. 2019, 26, 87-88. https://doi.org/10.3747/co.26.4975

AMA Style

Mittmann N. Why Are We Organizing Another Costing Supplement in Current Oncology? Current Oncology. 2019; 26(2):87-88. https://doi.org/10.3747/co.26.4975

Chicago/Turabian Style

Mittmann, N. 2019. "Why Are We Organizing Another Costing Supplement in Current Oncology?" Current Oncology 26, no. 2: 87-88. https://doi.org/10.3747/co.26.4975

APA Style

Mittmann, N. (2019). Why Are We Organizing Another Costing Supplement in Current Oncology? Current Oncology, 26(2), 87-88. https://doi.org/10.3747/co.26.4975

Article Metrics

Back to TopTop